Loading Events

European Prefilled Syringes Summit

Date: 6th September 2017 - 7th September 2017 Location: Berlin - Germany

After the success of our first European Prefilled Syringes Summit, we are pleased to announce the next edition which shall take place on the 6th & 7th September in Berlin, Germany.

The global market for pre-filled syringes will grow substantially over the next five years to reach sales of $6.6 billion, according to a new report from Smithers Rapra. With sales of $6.9 billion expected by 2018, syringes of this kind cater to an expanding patient demographic: people with chronic conditions who need, or prefer, to administer their own medicines. The race is on to improve the associated technologies, ensuring that the new generation of prefilled syringes can adequately accommodate tomorrow’s drugs.

Biopharmaceutical packaging is changing. As pharmaceutical manufacturers embrace more flexible processes that limit the risk of product contamination, packaging and containment systems are being designed to facilitate manufacturing of smaller product lots and batches. Some fill/finish operations are moving to fully enclosed, automated operation, requiring the use of not only nested syringes and closures, but also nested vials and caps, and manufacturers are working to standardize these components. Designers of primary packaging and delivery system components have had to change their approach to product development.

ACI’s European Prefilled Syringes Summit will explore the advancements in regulatory guidelines, product development, manufacturing processes, risk mitigation , portfolio management and answer some infinite industry questions such as; how the industry is responding to disruptive technology, connectivity, speed to market, and next generation syringes. . There are several elements that pose a severe challenge to the growth of the global prefilled syringes market, the primary one being the high costs associated with temperature controlled packaging required for temperature-sensitive drugs. Other more traditional factors inhibiting the market include product recalls due to breakages and leachables, the potential risk of interaction between prefilled syringes and drugs, and needle stick prevention.

If you would like to be considered as a speaker for the event with a 30-45 minute presentation, please submit an abstract for consideration to:

Chloe Wates
Tel: +44 (0)20 3141 0638
Email: cwates@acieu.net

 

Tickets

European Prefilled Syringes Summit - Conference Pass (Inc. Documentation Package)£1,275.00After £320 Early Bird Discount - Full Conference Pass. Standard Price £1595
European Prefilled Syringes Summit - Documentation Package Only£420.00

Details

Start:
6th September 2017
End:
7th September 2017
Event Category:

Contact

Name:
Chloe Wates – Content
Phone:
+44 (0)20 3141 0638
Email:
Name:
Mohammad Ahsan – Marketing, Delegate Sales & Media Partnerships
Phone:
+44 (0) 203 141 0606
Email:
Name:
Timothy Rowley-Evans – Sponsorship
Phone:
+442031410637
Email:
Name:
Claire Taylor-Payne – Logistics
Phone:
+ 44 (0)20 3141 0601
Email:

Venue

We will confirm the venue approximately 4-6 weeks before the event to ensure we find the most suitable space because numbers can vary dramatically. There will be a discounted accommodation rate for conference attendees.
London, United Kingdom
+ Google Map

European prefilled syringes market & growth opportunities

  • The evolving state of the market with respect to key players and geographies
  • Trends in modern biologics targeting therapeutic classes of drugs that are considered to be the primary growth drivers within the market
  • Lessons learned and latest market needs for PFS
  • Are next generation device factors such as connectivity & sustainability driving new demands?
  • Latest FDA guidelines
  • Inspection trends, and usability studies
  • Anti-counterfeit strategies

Regulatory Trends 

  • Latest Regulatory Submission Strategies & Overcoming Complex Requirements for Approval
  • Device related changes in the EU
  • Quality culture from a regulatory perspective
  • Microneedles and the latest transdermal delivery systems
  • Specialty syringes, which include prefilled flush syringes, prefilled diluent systems and contrast agents in prefilled syringe
  • Inspection trends, and usability studie
  • Anti-counterfeit strategies
  • Speed to market and complex product manufacturing
  • Minimizing interaction between theclosure system and the drug formulation
  • Technical collaborative success case study: product overview

Concentrating on Next Generation Smart Devices while Overcoming Traditional Challenges

  • Smart devices: their emerging role in auto-injector systems & driving innovation
  • Improving quality, connectivity, and cost control for combination products & autoinjector
  • Patient engagement and adherence -compliance with new products requires constant engagement with the target patient population and other applicable stakeholders throughout the design and commercialization
  • Overcoming technical challenges for building connectivity and sensors into new devices

The Drug/Device interface 

  • initegration of the formulation and the device

Device development and manufacturing

  • Next Generation Materials & Design of Pre-Filled Syringes
  • Usability: Key Human Factor Attributes & Interactive Considerations
  • The challenges of product classes
  • Patient Centric Design Updates for Pre-Filled Syringe applications
  • Challenges of paediatric drug delivery & Injectability of highly concentrated protein formulations
  • Managing the Materials used to Construct Pre-Filled Syringes—Selection and Supply Chain Control

Business development and marketing

  • Balancing biopharmaceutical product portfolio for continual product innovation, such as incorporating a new delivery component and Creating a lower-risk product development strategy
  • Improving Safety Standards Driving High Costs Associated with Prefilled Syringes Inhibiting widespread Adoption – Best practices in cost control
  • Driving quality & commercial competitiveness
  • Increasing demand for single use & reusable devices
  • Patient engagement and adherence -compliance with new products requires constant engagement with the target patient population and other applicable stakeholders throughout the design and commercialization

The two day event will provide an unique platform for collaboration and discussion between a variety of industry perspectives including manufacturers, suppliers, academia and regulators homing in on the latest opportunities arising from the prefilled syringes industry.

The aim is to identify potential solutions, future work programmes and productive partnerships that overcome the key regulatory challenges and facilitate minimizing risk within the supply chain promoting access to safe and effective biologicals.

  • Demonstrate how big data can be applied to design and
    optimize manufacturing processes
  • Define strategies to accelerate new products to the market
  • Interpret the latest trends in microbiological and adventitious
    agent control strategies
  • Explain delivery system design and manufacturing logistics for
    patient-centered therapies and precision medicine
  • Learn how devices serve the disease space by category
  • Summarize best practices for identifying and introducing new
    technologies

Dr. Nicolas Brandes, Director Market Development Europe/Asia Pacific, West Pharmaceuticals 

Andrew Feilden, Chemistry Operations Director, Smithers Rapra

If you would like to be considered as a speaker for the event with a 30-45 minute presentation, please submit an abstract for consideration to:


Chloe Wates

Tel: +44 (0)20 3141 0638

Email: cwates@acieu.net

Senior management within R&D:

  • Academics and Innovators
  • National and International Regulators and public health organisations
  • Policy makers and funding agencies.
  • Materials Suppliers
  • Pre-Filled Syringes/ Device Development
  • Product Management
  • Application Specialists
  • Senior Packaging Engineers
  • Advisory Consultants
  • Finished Products and Medical Devices
  • Device and Delivery Injectables

ACI has put together a range of packages to suit your requirements. These range from branding options, to full scale partner solutions and can be tailored to meet your objectives and budgets.

If you are launching a new product or service and wish to gain visibility and brand recognition within your industry, contact us today!

For commercial opportunities, please contact:


Tim Rowley-Evans

Tel: +44 20 3141 0637

Email: trowleyevans@acieu.net